Fundraising FoxCancer Prevention Pharmaceuticals
Tucson, US · Delaware corporation
Find your way into Cancer Prevention Pharmaceuticals
Sign up to see every warm intro you have to Cancer Prevention Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cancer Prevention Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JJ
Jeffrey JacobNamed on SEC filing
EG
Eugene Gerner, Ph.D.Named on SEC filing
Board
JS
Jon SaxeBoard director
DD
Daniel DonovanBoard director
RL
Richard LoveBoard director
Reported raises · per SEC filings
Form D private placements$11.9M disclosed across 5 rounds · 2015–2021
▶$400KraisedJan 2021 · 6 investors · BiotechnologyRule 506(b)
▶$400KraisedJan 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard LoveDirector
- John SaxeDirector
- Eugene Gerner, Ph.D.Director
- Jeffrey JacobExecutive Officer, Director
- Daniel DonovanDirector
- Andrew LevitchExecutive Officer
- Offering amount
- $3M
- Amount sold
- $400K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedSep 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$5MraisedSep 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard LoveDirector
- Jeffrey JacobExecutive Officer, Director
- Jon SaxeDirector
- Christopher RichiedExecutive Officer
- Eugene Gerner, Ph.D.Director
- Daniel DonovanDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$700KraisedApr 2017 · 8 investors · PharmaceuticalsRule 506(b)
▶$700KraisedApr 2017 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Daniel DonovanDirector
- Jon SaxeDirector
- Jeffrey JacobExecutive Officer, Director
- Christopher RichiedExecutive Officer
- Eugene Gerner, Ph.D.Director
- Richard LoveDirector
- Offering amount
- $3M
- Amount sold
- $700K
- Minimum investment
- $10K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedJan 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$5MraisedJan 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jon SaxeDirector
- Eugene Gerner, Ph.D.Director
- Jeffrey JacobExecutive Officer, Director
- Richard LoveDirector
- Daniel DonovanDirector
- Christopher RichiedExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- Sales commissions
- $250K
- Placement agents
- Financial West Group
- First sale
- Jan 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$835KraisedJan 2016 · 14 investors · PharmaceuticalsRule 506(b)
▶$835KraisedJan 2016 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jon SaxeDirector
- Christopher RichiedExecutive Officer
- Jeffrey JacobExecutive Officer, Director
- Eugene Gerner, Ph.D.Director
- Daniel DonovanDirector
- Richard LoveDirector
- Offering amount
- $3M
- Amount sold
- $835K
- Minimum investment
- $25K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cancer Prevention Pharmaceuticals raised?
- Cancer Prevention Pharmaceuticals has disclosed $11.9M raised across 5 rounds.
- Where is Cancer Prevention Pharmaceuticals headquartered?
- Cancer Prevention Pharmaceuticals is headquartered in Tucson, US.